U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: July 16-22, 2023
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: July 16-22, 2023

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 07/17/2023
Location: Silver Spring, MD
Subject: Obesity Treatments
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Bill Dietz (STOP Obesity Alliance); Anthony Comuzzie, Daniel Bessesen (The Obesity Society); Joe Nadglowski, Ted Kyle (Obesity Action Coalition); Michael Kolber, Rachel Sher (Manatt);

Event Date: 07/17/2023
Location: Virtual
Subject: Nutrition Priorities
FDA Participant/Group: DAYLE CRISTINZIO; LAURA CARROLL; ROBIN MCKINNON;
Non FDA Participant/Group: Several members of the American Medical Association

Event Date: 07/18/2023
Location: Virtual
Subject: Milken Institute FasterCures Changemakers
FDA Participant/Group: DAYLE CRISTINZIO;
Non FDA Participant/Group: Industry

Event Date: 07/20/2023
Location: Virtual
Subject: Diversity in Clinical Trials
FDA Participant/Group: NAMANDJE BUMPUS; DAYLE CRISTINZIO;
Non FDA Participant/Group: Industry, academia, media, and government

Event Date: 07/20/2023
Location: Virtual
Subject: Pfizer Rocky Mount Facility
FDA Participant/Group: ANDREW ZACHER; JULIA TIERNEY; HILARY MARSTON;
Non FDA Participant/Group: Albert Bourla (Pfizer);

Event Date: 07/22/2023
Location: Virtual
Subject: Pfizer Rocky Mount Facility
FDA Participant/Group: ANDREW ZACHER; HILARY MARSTON; JULIA TIERNEY;
Non FDA Participant/Group: Albert Bourla (Pfizer);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Carol Cave, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 07/18/2023
Location: Washington, DC
Subject: National Student Leadership Conference at American University; Realizing the Promise of Gene Therapy in Humans
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the National Student Leadership Conference at American University

Event Date: 07/18/2023
Location: Virtual
Subject: Biocom California Meeting; Update on FDA's Cell and Gene Therapy Initiatives and Regulatory Policy Advancements
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Biocom California Meeting

Event Date: 07/20/2023
Location: Washington, DC
Subject: Politico Live Meeting; The Next Generation of Health Care Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Politico Live Meeting; The Next Generation of Health Care Therapies

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 07/17/2023
Location: Toronto, Canada
Subject: International Association for Food Protection Annual Meeting; Update on Human Foods Program
FDA Participant/Group: MARK MOORMAN;
Non FDA Participant/Group: Industry, regulatory, and other stakeholders

Event Date: 07/19/2023
Location: Virtual
Subject: Health Chemicals Coalition Meeting
FDA Participant/Group: STEVE HERMANSKY; SUSAN LAINE; JESSICA ROWDEN; ELISABETH DAVIS; GRACE KIM; STEVEN MUSSER; KRISTI MULDOON JACOBS; KARI BARRETT; KRISTINE BUTLER; PAUL SOUTH; DOUGLAS STEARN;
Non FDA Participant/Group: Jane Houlihan, Charlotte Brody (Healthy Babies Bright Futures ); Tom Neltner, Carrie Murton, Joanne Staney, Liora Fikse (Environmental Defense Fund); Thomas Galligan, Jensen Jose (Center for Science in the Public Interest); Tunde Akinieye, Michael Hansen (Consumer Reports); Scott Faber, Melanie Benesh, Lillian Zhou (Environmental Working Group); Jaydee Hansen (Center for Food Safety);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 07/18/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from Smoke Free Alternatives Trade Association (SFATA)

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top